Latest stories

  • FDA Approves New Meningococcal Disease Vaccine

    FDA Approves Second Vaccine to Prevent Serogroup B Meningococcal Disease

    The Food and Drug Administration (FDA) has approved a second vaccine for individuals between the ages of 10 and 25 years old to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B: Bexsero. Meningococcal disease refers to any illness caused by the bacteria Neisseria meningitidis. Meningococcus bacteria spread through the exchange of respiratory and […] More